In vitro-induced response patterns of antileukemic T cells: characterization by spectratyping and immunophenotyping-Reference-Cited by-同舟云学术

In vitro-induced response patterns of antileukemic T cells: characterization by spectratyping and immunophenotyping

Published:2012-03-23 Issue:1 Volume:13 Page:29-48
ISSN:1591-8890
Container-title:Clinical and Experimental Medicine
language:en
Short-container-title:Clin Exp Med

Author:

Reuther Susanne,Schmetzer Helga,Schuster Friedhelm R.,Krell Pina,Grabrucker Christine,Liepert Anja,Kroell Tanja,Kolb Hans-Jochem,Borkhardt Arndt,Buhmann Raymund

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s10238-012-0180-y.pdf

Reference44 articles.

1. Giles FJ, Keating A, Goldstone AH, Avivi I, Willman CL, Kantarjian HM (2002) Acute myeloid leukemia. Hematol Am Soc Hematol Educ Program 73–110

2. Buchner T, Hiddemann W, Berdel WE, Wormann B, Schoch C, Fonatsch C, Loffler H, Haferlach T, Ludwig WD, Maschmeyer G, Staib P, Aul C, Gruneisen A, Lengfelder E, Frickhofen N, Kern W, Serve HL, Mesters RM, Sauerland MC, Heinecke A (2003) 6-Thioguanine, cytarabine, and daunorubicin (TAD) and high-dose cytarabine and mitoxantrone (HAM) for induction, TAD for consolidation, and either prolonged maintenance by reduced monthly TAD or TAD-HAM-TAD and one course of intensive consolidation by sequential HAM in adult patients at all ages with de novo acute myeloid leukemia (AML): a randomized trial of the German AML cooperative group. J Clin Oncol 21(24):4496–4504. doi: 10.1200/JCO.2003.02.133

3. Kolb HJ, Schmid C, Barrett AJ, Schendel DJ (2004) Graft-versus-leukemia reactions in allogeneic chimeras. Blood 103(3):767–776. doi: 10.1182/blood-2003-02-0342

4. Kolb HJ, Mittermuller J, Clemm C, Holler E, Ledderose G, Brehm G, Heim M, Wilmanns W (1990) Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood 76(12):2462–2465

5. Kolb HJ, Schattenberg A, Goldman JM, Hertenstein B, Jacobsen N, Arcese W, Ljungman P, Ferrant A, Verdonck L, Niederwieser D, van Rhee F, Mittermueller J, de Witte T, Holler E, Ansari H (1995) Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. Blood 86(5):2041–2050

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dendritic cell vaccination strategy for the treatment of acute myeloid leukemia: a systematic review;Cytotherapy;2024-05

2. Molecular mechanisms augmenting resistance to current therapies in clinics among cervical cancer patients;Medical Oncology;2023-04-15

3. ARE DENDRITIC CELLS A POTENTIAL TOOL FOR MASTITIS VACCINE DEVELOPMENT?;Journal of microbiology, biotechnology and food sciences;2023-01-31

4. Research progress on dendritic cell vaccines in cancer immunotherapy;Experimental Hematology & Oncology;2022-01-24

5. Potential of immunotherapies in the mediation of antileukemic responses for patients with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) - With a focus on Dendritic cells of leukemic origin (DCleu);Clinical Immunology;2020-08